Clinical Trial Update: Diadem to Investigate the Activity and Safety of Durvalumab [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating durvalumab activity and safety in pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Mesothelioma

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Pleura Mesothelioma | Phase 2 | Status: COMPLETED